Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Rosalind Advisors, Inc.
Form 13F · Q2 2026

Rosalind Advisors, Inc.

CIK 1622627申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$2.7亿
申报组合市值
35
持仓数量
11
Quarters on record
Top 50
持仓数量

Rosalind Advisors, Inc.——持仓

共 35 个持仓中的前 29 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1DCTH Delcath Sys Inc3.3M+0.0%$4155万15.4%
2FENC Fennec Pharmaceuticals Inc3.2M+9.6%$3427万12.7%
3XERS Xeris Biopharma Holdings Inc2.9M−10.0%$2304万8.6%
4SVRA Savara Inc3.2M−0.8%$1958万7.3%
5VSTM Verastem Inc4.0M+86.4%$1523万5.7%
6XFOR X4 Pharmaceuticals Inc3.2M+0.0%$1501万5.6%
7EYPT Eyepoint Inc988,230−4.7%$1413万5.2%
8HELP Cybin Inc2.0M+27.7%$1293万4.8%
9VOR Vor Biopharma Inc648,600−7.3%$1194万4.4%
10PCVX Vaxcyte Inc200,000−31.0%$1163万4.3%
11MDWD Mediwound Ltd749,054+0.0%$1101万4.1%
12CLDX Celldex Therapeutics Inc New200,000−39.4%$744万2.8%
13BCRX Biocryst Pharmaceuticals Inc721,504−21.8%$722万2.7%
14PROF Profound Med Corp828,118+0.0%$551万2.0%
15TLPH Talphera Inc5.2M+54.1%$532万2.0%
16AVIR Atea Pharmaceuticals Inc1.1M−8.6%$498万1.8%
17MYO Myomo Inc3.6M−5.4%$378万1.4%
18OVID Ovid Therapeutics Inc1.1M+0.0%$298万1.1%
19NRXS Neuraxis Inc508,055+77.6%$297万1.1%
20ABVX Abivax Sa20,869—$278万1.0%
21NSPR Inspiremd Inc3.9M+0.0%$273万1.0%
22RGNT Regentis Biomaterials Ltd701,685+179.0%$248万0.9%
23PYPD Polypid Ltd389,455−34.9%$198万0.7%
24BFRI Biofrontera Inc1.3M+9.6%$121万0.4%
25KURA Kura Oncology Inc100,000+0.0%$110万0.4%
26SPRB Spruce Biosciences Inc20,000—$108万0.4%
27AQST Aquestive Therapeutics Inc250,000+0.0%$104万0.4%
28OKUR Onkure Therapeutics Inc150,000−66.2%$68万0.3%
29PEPG Pepgen Inc350,000—$63万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。